Herein, we therefore assessed the role of eCAT volume for coronary plaque burden by CCTA, its association with established biomarkers of myocardial injury (hs-TnT) and inflammation (hs-CRP), and investigated its prognostic value in presumably stable CAD patients. This evidence concerns the gene MAP3K14 and coronary artery disorder.